Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07375095 · ClinicalTrials.gov registry record · NA

A Study of a Sleep Supplement to Improve Sleep in Women Going Through Menopause

A NA study of Sleep Disturbance, sponsored by Bonafide Health.

Completed
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT07375095 is a NA study of Sleep Disturbance that has completed, run by Bonafide Health. The registered enrollment target is 128 participants, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07375095, a NA study of Sleep Disturbance, has completed, sponsored by Bonafide Health.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

This study evaluated whether a daily dietary sleep supplement could improve sleep in women aged 40 to 65 who experience moderate sleep disturbances during menopause. Participants were randomly assigned to take either the supplement or a placebo for about three weeks. All study visits were conducted virtually. Sleep was assessed through daily diaries and weekly questionnaires measuring sleep quality, nighttime awakenings, daytime alertness, and mood. The study's goal was to compare changes between the supplement and placebo groups and to assess safety and tolerability during the study period.

Conditions Studied

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Sleep Supplement

Study Locations (1)

New York

  • Bonafide Health, LLC - Harrison

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2023-10-10
Est. Completion 2024-04-07
Phase NA

Sponsor

Bonafide Health

5 total trials

What the Registry Record Tells You About NCT07375095

The ClinicalTrials.gov registry entry for NCT07375095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (27% lower). The listed sponsor is Bonafide Health, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Disturbance appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07375095 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07375095 about?

NCT07375095 is a clinical study titled "A Study of a Sleep Supplement to Improve Sleep in Women Going Through Menopause". This study evaluated whether a daily dietary sleep supplement could improve sleep in women aged 40 to 65 who experience moderate sleep disturbances during menopause. Participants were randomly assigned to take either the supplement or a placebo for about three weeks. All study visits were conducted ...

What is the current status of trial NCT07375095?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2023-10-10. Estimated completion is 2024-04-07.

What conditions does trial NCT07375095 study?

This clinical trial studies the following conditions: Sleep Disturbance.

What interventions are being tested in trial NCT07375095?

The interventions under investigation include: Placebo (DRUG), Sleep Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07375095?

This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07375095 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disturbance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.